# A Multicenter, Open Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Parietaria Judaica

> **NCT02477917** · PHASE1 · COMPLETED · sponsor: **Roxall Medicina España S.A** · enrollment: 51 (actual)

## Conditions studied

- Rhinoconjunctivitis

## Interventions

- **BIOLOGICAL:** Allergovac depot with Parietaria judaica pollen extract

## Key facts

- **NCT ID:** NCT02477917
- **Lead sponsor:** Roxall Medicina España S.A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2017-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02477917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02477917, "A Multicenter, Open Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Parietaria Judaica". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02477917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*